The connection between NAD⁺ and female hormones is one of the most significant and yet least discussed findings in longevity research. Here, you will learn what it means for your cycle and perimenopause, and why the symptoms that most women accept as normal have a cellular explanation that no one has ever provided them with.
Women who experience worsening PMS, a luteal phase that becomes more difficult every year, or perimenopausal symptoms that arrive earlier than expected are usually given one of two explanations: It’s hormonal. Or it’s stress.
Both answers fall short. The hormonal explanation is partially correct but omits a crucial level: the cellular one. The stress explanation is almost always off the mark regarding the root cause; the only truth is that something has fallen out of balance.
What neither answer explains is why hormonal regulation becomes less efficient with age. Why the same hormonal fluctuations that were easy to handle at 28 become overwhelming at 38. And what is happening in the cell that causes this.
NAD⁺ is the missing piece of this explanation. Its decline affects more than just energy and sleep. It directly impairs the enzymatic processes that produce and regulate sex hormones.
This means: As NAD⁺ levels drop in your 30s and 40s, the hormonal system loses its cellular support at the exact moment when the hormonal landscape is shifting anyway. Both processes reinforce each other. And the result is something that women are usually just told to learn to cope with, rather than understand.
The direct link between NAD⁺ and progesterone
The enzyme that converts pregnenolone into progesterone is called 3β-hydroxysteroid dehydrogenase. It cannot function without NAD⁺ as a cofactor.
This is not an indirect or secondary relationship. NAD⁺ is structurally necessary for this enzyme to work. If NAD⁺ levels drop, the enzyme's ability to efficiently produce progesterone drops with it.
Progesterone is the dominant hormone of the luteal phase, the second half of the cycle. It maintains the uterine lining, regulates mood, supports sleep quality in the second half of the month, and dampens the inflammatory response behind cramps and PMS symptoms.
This means: The slump in the luteal phase that many women know—the unstable mood, disturbed sleep, energy crashes, worsening PMS—is not a purely hormonal event. At least not in the sense that it could be fixed on a hormonal level alone. Part of the problem is that the cells producing progesterone simply lack the NAD⁺ to do so efficiently.
Restoring NAD⁺ does not replace declining hormones. But it does restore the cellular conditions under which these hormones are created. And that is a fundamentally different approach than anything found in the usual discussion about hormonal health.
Why perimenopause hits harder than it should
Perimenopause can begin as early as 35. Menopause itself occurs on average between 51 and 52 years of age. During this entire period, NAD⁺ levels are simultaneously declining.
This means: The hormonal system is losing its primary hormones, and the cells that support these hormones are losing their most important energy source at the same time.
The hormonal fluctuations of perimenopause are destabilizing on their own. Estrogen and progesterone levels begin to fluctuate unpredictably. Sleep is disrupted. Mood becomes more labile. And the body’s stress response changes.
When these fluctuations meet a declining NAD⁺ level, the cellular systems that would otherwise buffer them are also weakened. This is a key reason why perimenopause is usually experienced as more difficult than expected, and why the standard reassurance that "it’s all normal" rarely fits what women are actually going through.
What human research shows
The most significant NMN study in humans to date was conducted specifically with postmenopausal women. Not because this group was easy to recruit, but because both hormonal and NAD⁺ decline are most advanced in this group, making the metabolic consequences of both most easily measurable.
In 2021, Yoshino et al. published in Science that daily NMN intake over ten weeks significantly improved insulin sensitivity in muscle tissue. Additionally, the activity of genes involved in muscle tissue remodeling increased.
Insulin sensitivity in muscle tissue is directly relevant to hormonal health. Insulin resistance and impaired regulation of sex hormones are closely linked, especially during peri- and postmenopause.
There are currently few human studies that directly measure the effect of NMN on progesterone levels, cycle regularity, or luteal phase complaints. This should be stated honestly.
The mechanism of action is documented, and the metabolic data from human studies align with what biology would lead us to expect. Specific hormone research for women is only just being built. This, too, is a symptom of the same research gap that has left women’s health underfunded for decades.
What NMN does not do
NMN is not a hormone replacement and does not act like one. It does not directly raise estrogen or progesterone levels. And it does not resolve clinical hormone deficiencies.
Women with diagnosed hormonal conditions—PCOS, endometriosis, premature ovarian insufficiency—should not view NMN as a substitute for medical treatment or medically indicated hormone therapy.
What NMN does is something else: it restores the cellular energy environment in which hormonal processes occur. That is an effective approach, but a different one than hormone therapy.
This distinction is important to ensure realistic expectations and so that NMN is used for what it is: a cellular intervention that supports hormonal function, not a replacement for the hormones themselves.
What women who take NMN consistently report
Women who take NMN for three months or longer and track their cycle report predominantly the same thing: the second half of the month becomes noticeably easier. Usually starting from the first or second month.
The luteal phase does not disappear. Hormonal fluctuations still occur. But it no longer feels like you have to meet the same demands with a fraction of the fuel.
Energy remains more consistent throughout the month. Sleep in the second half of the cycle improves. And the PMS symptoms that were becoming stronger year after year begin to stabilize.
None of this can be promised on a fixed timeline, and individual differences are real. But the pattern is so consistent across reports from women that it reflects biology, not coincidence.